Lunatic Fringe
From the "Complete and total Miscarriage of Justice" Department:In case readers missed it with all the coverage of the Trayvon Martin murder trial and the Supreme Court’s rulings on gay marriage and the Voting Rights Act, the US Supreme Court also made a ruling on lawsuits against drug companies for fraud, mislabeling, side effects and accidental death. From now on, 80 percent of all drugs are exempt from legal liability.
Drug
companies failed to warn patients that toxic epidermal necrolysis was a
side effect. But the Supreme Court ruled they're still not liable for
damages.
In
a 5-4 vote, the US Supreme Court struck down a lower court’s ruling and
award for the victim of a pharmaceutical drug’s adverse reaction.
According to the victim and the state courts, the drug caused a
flesh-eating side effect that left the patient permanently disfigured
over most of her body. The adverse reaction was hidden by the drug maker
and later forced to be included on all warning labels. But the highest
court in the land ruled that the victim had no legal grounds to sue the
corporation because its drugs are exempt from lawsuits.
Karen Bartlett vs. Mutual Pharmaceutical Company
In 2004, Karen Bartlett was prescribed the generic anti-inflammatory
drug Sulindac, manufactured by Mutual Pharmaceutical, for her sore
shoulder. Three weeks after taking the drug, Bartlett began suffering
from a disease called, ‘toxic epidermal necrolysis’. The condition is
extremely painful and causes the victim’s skin to peel off, exposing raw
flesh in the same manner as a third degree burn victim.
Karen Bartlett sued Mutual Pharma in New Hampshire state court,
arguing that the drug company included no warning about the possible
side effect. A court agreed and awarded her $21 million. The FDA went on
to force both Mutual, as well as the original drug manufacturer Merck
& Co., to include the side effect on the two drugs’ warning labels
going forward.
Now, nine years after the tragedy began, the US Supreme Court
overturned the state court’s verdict and award. Justices cited the fact
that all generic drugs and their manufacturers, some 80% of all drugs
consumed in the United States, are exempt from liability for side
effects, mislabeling or virtually any other negative reactions caused by
their drugs. In short, the Court ruled that the FDA has ultimate
authority over pharmaceuticals in the US. And if the FDA says a drug is
safe, that takes precedent over actual facts, real victims and any and
all adverse reactions.
Court ruling
The Court’s ruling a week ago on behalf of generic drug makers is
actually a continuation of a ruling made by the same Court in 2011. At
that time, the Justices ruled that the original inventors and
manufacturers of pharmaceutical drugs, also known as ‘name brand’ drugs,
are the only ones that can be sued for mislabeling, fraud or adverse
drug reactions and side effects. If the generic versions of the drugs
are made from the exact same formula and labeled with the exact same
warnings as their brand name counterparts, the generics and their
manufacturers were not liable.
The Court ruled, “Because it is impossible for Mutual and other
similarly situated manufacturers to comply with both state and federal
law, New Hampshire's warning-based design-defect cause of action is
pre-empted with respect to FDA-approved drugs sold in interstate
commerce."
And that ruling flies in the face of both common sense and justice.
And as Karen Bartlett can now attest, it leaves 240 million Americans
unprotected from the deadly and torturous side effects of pharmaceutical
drugs. As a reminder, the number one cause of preventable or accidental
death in the US is pharmaceutical drugs.
Critics react
Immediately upon the Supreme Court’s ruling, both drug manufacturers
and Wall Street investors were celebrating. As one financial analyst
pointed out, drug company profits should skyrocket going forward. Not
only do the pharmaceutical companies no longer have to worry about
safety or side effects, they are exempt from the multi-million dollar
court-imposed settlements awarded to victims of their drugs.
One industry critic was quoted by Reuters
after the verdict. "Today's court decision provides a disincentive for
generic makers of drugs to monitor safety of their products and to make
sure that they have a surveillance system in place to detect adverse
events that pose a threat to patients," Michael Carome, director of
Public Citizen's Health Research Group told the news outlet.
Senate Judiciary Committee Chairman Patrick Leahy (D-VT) was quick to
react to the ruling by writing a stern letter to FDA Commissioner
Margaret Hamburg, "A consumer should not have her rights foreclosed
simply because she takes the generic version of a prescription drug.”
But an attorney for the drug companies, Jay P. Lefkowitz, took the
opposing position saying, “It makes much more sense to rely on the
judgments of the scientific and medical experts at the FDA, who look at
drug issues for the nation at large, than those of a single state court
jury that only has in front of it the terribly unfortunate circumstances
of an adverse drug reaction."
In other words, if the FDA says something is safe, it doesn’t matter
if that decision is wrong or the result of lies, fraud or deception on
the part of the world’s pharmaceutical companies. And there’s no way to
sue the FDA for being wrong and costing millions of unsuspecting
Americans their lives. That result leaves 240 million Americans
unprotected from an industry responsible for more preventable deaths in
the US than any other cause.
No comments:
Post a Comment